Records 1 - 5
| ATM mutations improve radio-sensitivity in wild-type isocitrate dehydrogenase-associated high-grade glioma: retrospective analysis using next-generation sequencing data.
Radiation oncology (London, England) 2020 Jul 15 (1): 184.
Kim Nalee, Kim Se Hoon, Kang Seok-Gu, Moon Ju Hyung, Cho Jaeho, Suh Chang-Ok, In Yoon Hong, Chang Jong H
| Second-line dovitinib (TKI258) in patients with FGFR2-mutated or FGFR2-non-mutated advanced or metastatic endometrial cancer: a non-randomised, open-label, two-group, two-stage, phase 2 study.
The Lancet. Oncology 2015 Jun 16 (6): 686-94.
Konecny Gottfried E, Finkler Neil, Garcia Agustin A, Lorusso Domenica, Lee Paula S, Rocconi Rodney P, Fong Peter C, Squires Matt, Mishra Kaushal, Upalawanna Allison, Wang Yongyu, Kristeleit Rebec
| GATA2 mutations in patients with acute myeloid leukemia-paired samples analyses show that the mutation is unstable during disease evolution.
Annals of hematology 2015 Feb 94 (2): 211-21.
Hou Hsin-An, Lin Yun-Chu, Kuo Yuan-Yeh, Chou Wen-Chien, Lin Chien-Chin, Liu Chieh-Yu, Chen Chien-Yuan, Lin Liang-In, Tseng Mei-Hsuan, Huang Chi-Fei, Chiang Ying-Chieh, Liu Ming-Chih, Liu Chia-Wen, Tang Jih-Luh, Yao Ming, Huang Shang-Yi, Ko Bor-Sheng, Hsu Szu-Chun, Wu Shang-Ju, Tsay Woei, Chen Yao-Chang, Tien Hwei-Fa
| Efficacy of EGFR tyrosine kinase inhibitors in non-small-cell lung cancer patients with/without EGFR-mutation: evidence based on recent phase III randomized trials.
Medical science monitor : international medical journal of experimental and clinical research 2014 20 2666-76.
Zhang Wen-Qian, Li Tong, Li H
| Impact of NOTCH1/FBXW7 mutations on outcome in pediatric T-cell acute lymphoblastic leukemia patients treated on the MRC UKALL 2003 trial.
Leukemia 2013 Jan 27 (1): 41-7.
Jenkinson S, Koo K, Mansour M R, Goulden N, Vora A, Mitchell C, Wade R, Richards S, Hancock J, Moorman A V, Linch D C, Gale R